Navigation Links
Epigenetics: Changing the Way We Think about DNA
Date:3/7/2013

Irvine, CA (PRWEB) March 07, 2013

Zymo Research Corporation, a privately held company located in Irvine, California, has recently expanded its range of tools and services for scientists working in one of the hottest fields of science today – Epigenetics. Zymo Research now offers the most comprehensive suite of services for epigenetic analysis, including genome-wide platforms for profiling DNA methylation and hydroxymethylation, ChIP-Seq, nucleosome mapping, RNA-Seq, and more. These services are intended to assist academic and industry scientists investigate the role epigenetics plays in a variety of applications – one of the largest being healthcare. Epigenetics research has the potential to completely revolutionize modern medicine through the advancement of personalized therapies, cancer treatment, stem cell research, and drug development.

As one of the Top 10 Scientific Discoveries of 2009, according to TIME magazine, efforts to decode the epigenome are notably one of the most exciting and rapidly expanding areas in biology. While it was previously believed that the primary DNA sequence contained all of the information required for heredity, scientists now agree that genetics alone can never fully explain why we develop as we do. Now, epigenetics can help provide answers to questions such as why identical twins that share the same DNA sequence can end up developing differently and why some of us develop cancers and various other diseases, while others do not. Furthermore, the study of this field may answer the age-old question of nature versus nurture and how environmental factors such as nutrition, stress, age, and illness can cause heritable traits without changing the underlying DNA sequence.

According to Dr. Marc Van Eden, V.P. of Business Development at Zymo Research, “Making genome-wide epigenetic analyses available to all researchers will mark the beginning of a new era in epi-biomarker discovery and validation that will aid in the diagnostics and prognostics of human diseases. Epigenetics research will also facilitate advancements in personalized medicine and companion diagnostics to optimize the efficiency of individualized drug treatment. We may begin to ask how things like the environment and our diet affect who we are and who we will likely become.” With genome-wide and targeted epigenetic sequencing services, companies like Zymo Research make profiling the epigenome of patients a reality. Such advancements will become crucial in furthering our understanding of science and medicine and should have a significant impact on how we diagnose and treat human diseases in the future.

For more information or to inquire about the epigenetic services, please contact Zymo Research at:

services(at)zymoresearch(dot)com
Tel: (949) 679-1190
Toll free: (888) 882-9682
http://www.zymoresearch.com/services

Zymo Research Corporation is a privately held biotechnology company located in Irvine, California that provides the highest quality epigenetics products and services, in addition to DNA and RNA purification products. The philosophy of the company is to provide the most innovative, quality products, while ensuring they are both simple and reliable to use.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10496662.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Game changing diagnostic & prognostic prostate cancer genetic tests revealed by Jefferson
2. Changing our material future, layer by layer
3. Fast forward to the past: NASA technologists test game-changing data-processing technology
4. A new take on the Midas touch -- changing the color of gold
5. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
6. Rethinking bacterial persistence
7. Probiotic Action Discusses Using Social Media to Teach the Public about Acne
8. Forget about leprechauns, engineers are catching rainbows
9. A gut feeling about neural stem cells
10. Genuine Bio-Fuel Clears the Air About Biodiesel In Wake of Recent Turmoil
11. Unknown Facts About Chronic Low Back Pain Treatment Revealed by the Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Feb. 21, 2017 Synthetic Biologics, Inc. (NYSE ... the microbiome to protect and restore the health of patients, intends ... December 31, 2016 on Thursday, March 2, 2017, and to host ... dial-in information for the call is as follows: U.S. ... ...
(Date:2/21/2017)... CA (PRWEB) , ... February 21, 2017 , ... ... to announce that Dr. Trevor Heritage has joined its executive team to lead ... system designed to provide insights to help improve the diagnosis and treatment of ...
(Date:2/21/2017)... VANCOUVER, British Columbia , Feb. 21, 2017 ... announced that apatorsen results from two randomized Phase 2 clinical ... (ASCO) 2017 Genitourinary Cancers Symposium, held February 16 th - ... data from trials in bladder and prostate cancers demonstrated apatorsen ... with standard-of-care treatments. ...
(Date:2/21/2017)... Feb 21, 2017 Research and Markets has ... Analysis & Trends - Industry Forecast to 2025" report to ... ... a CAGR of around 12.8% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
Breaking Biology Technology:
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/14/2017)...  Wake Forest Baptist Medical Center today announced Julie Ann ... officer (CEO). Freischlag joins the medical center on May ... M.D., who last year announced that he would transition ... leading it since 2008.   As CEO, ... Baptist,s academic health system, which includes Wake Forest School ...
(Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
Breaking Biology News(10 mins):